Results
Rapid increase in enrollment: Once patient financial barriers were removed through the DTP approach, enrollment rates significantly increased. Patients who previously could not afford insulin could now participate fully in the trial.
Enhanced patient experience: Participants no longer had to worry about traveling to clinical sites for regular visits, leading to a more positive experience, reduced patient burden, and fewer participant dropouts.
Operational efficiency: CTRx streamlined medication access and reduced the administrative burden on sites, allowing the sponsor to focus more on trial execution rather than logistics.